Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Biotech weighs up the options in obesity

Nature Biotechnology volume 19, pages 25–28 (2001)Cite this article

The perfect diet pill has eluded the drug industry for decades, but now molecular genetics has put the field on the map and offered new ways to fight the “battle of the bulge”.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The key elements of the body's weight-control system, highlighting the potential routes for therapeutic intervention.

©Bob Crimi

References

  1. Zhang, Y. et al. Nature 372, 425–432 (1994).

    Article  CAS  Google Scholar 

  2. Loftus, T.M., et al. Science 288, 2379– 2381 (2000).

    Article  CAS  Google Scholar 

Download references

Authors
  1. Alan Dove
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dove, A. Biotech weighs up the options in obesity. Nat Biotechnol 19, 25–28 (2001). https://doi.org/10.1038/83465

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/83465

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing